Global Motion Sickness Treatment Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Motion Sickness Treatment Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Motion sickness occurs when the brain receives conflicting information from the inner ear, eyes, and nerves in the joints and muscles. Motion Sickness often presents symptoms such as dizziness, nausea, cold sweats, and vomiting. Motion Sickness Treatment refers to products that provide the prevention or relief of motion sickness.

Market Overview:

The latest research study on the global Motion Sickness Treatment market finds that the global Motion Sickness Treatment market reached a value of USD 581.49 million in 2022. It’s expected that the market will achieve USD 790.6 million by 2028, exhibiting a CAGR of 5.25% during the forecast period.

Impact of COVID-19

The outbreak of the new crown epidemic has had a significant impact on the Motion Sickness Treatment industry. On the supply side, due to the huge impact of the epidemic on Motion Sickness Treatment's supply chain, the interruption of pharmaceutical raw materials, and the increase in manufacturing and sales costs, the company's profitability has also been significantly affected. From the perspective of demand, the new crown pneumonia epidemic continues to have a huge impact on the global economy. Countries have adopted border controls and restricted the flow of people within their borders to varying degrees, and even adopted strict measures such as home isolation under special circumstances. In this context, the global tourism industry has generally been hit and suffered huge financial losses. According to data released by the United Nations World Tourism Organization, the new crown pneumonia epidemic has led to a significant reduction in the number of global tourists, and the global tourism revenue in 2020 will lose 1.3 trillion US dollars. In addition, under the influence of the epidemic, economic activity has slowed down, people are working from home, travel is restricted, and the demand for various means of transportation has decreased. Therefore, as the number of tourists decreases and people travel less, there is less demand for Motion Sickness Treatment in the market. In general, the impact of the new crown epidemic has limited the development of the industry.

Increased chance of developing motion sickness

In modern society, people's chances of developing motion sickness are increasing. First, with the continuous development of the transportation industry, people have more and more opportunities to use transportation, so the possibility of motion sickness is also increasing. For example, with economic development, many companies operate across countries or regions. Therefore, employees often need to travel long distances to conduct business. Therefore, the chance of developing motion sickness is increasing. In addition, motion sickness is not only related to transportation, but people who experience VR often experience motion sickness. The main reason for VR motion sickness is that the eyes of people using VR glasses transmit information to their brains, telling the brain to move around with changes in the environment, but the user's body is standing still or sitting. Motion sickness occurs at this time, which is a symptom of conflicting human body information. In addition, with the increase of income levels, more and more people go to amusement parks and other facilities to try various projects, and many game projects will also cause symptoms of motion sickness. In general, with the development of modern society, the chances of people developing motion sickness are increasing, therefore, the market demand for Motion Sickness Treatment is increasing.

Side Effects of Motion Sickness Drugs

At present, the drugs commonly used to relieve motion sickness mainly include dimenhydrinate, scopolamine, etc., and each drug has corresponding indications. Among them, two over-the-counter drugs, dimenhydrinate and scopolamine, are more common. The most common adverse reactions of dimenhydrinate include dullness, drowsiness, and inability to concentrate. Dimenhydrinate is contraindicated in patients allergic to ethanolamines and pregnant women, and should be used with caution in patients with asthma, glaucoma, and prostatic hypertrophy. Scopolamine may cause discomfort such as thirst, blurred vision, drowsiness, palpitations, facial flushing, and headache. Scopolamine is contraindicated in patients with glaucoma, enlarged prostate, myasthenia gravis, and severe heart disease. For the development of the industry, the side effects of Motion Sickness Drugs are one of the challenges facing the development of the industry.

Region Overview:

Geographically, North America held the largest market share – 46.41% in 2022.

Company Overview:

Prestige Brands is one of the major players operating in the Motion Sickness Treatment market, holding a share of 14.77% in 2023.

Prestige Brands

Prestige Consumer Healthcare Inc. is an American company that sells and distributes over-the-counter healthcare and household cleaning products. At Prestige Consumer Healthcare, the company focuses on product innovation and quality in the over-the-counter healthcare category. The company mainly focuses on digestive health, eyes, ears, nose and throat, oral care, pain relief and other areas.

Baxter International

Baxter International Inc., through its subsidiaries, provides a broad portfolio of essential healthcare products, including acute and chronic dialysistherapies; sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectablepharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostictechnologies; and respiratory health devices.

Segmentation Overview:

Among different product types, Antihistamines segment is anticipated to contribute the largest market share in 2028.

Anticholinergic

Anticholinergic exerts anti-motion sickness effects by reducing parasympathetic excitability.

Antihistamines

Antihistamines exert a powerful anti-motion sickness effect by acting on the vestibular and emesis centers, blocking the excitation of cholinergic synaptic labyrinthine impulses in the vestibular nucleus.

Application Overview:

In the Motion Sickness Treatment market, 41.67% of the total value was generated through the Hospitals segment by application in 2022.

Key Companies in the global Motion Sickness Treatment market covered in Chapter 3:

Myungmoon Pharm
Prestige Brands
Tong Ren Tang
GlaxoSmithKline
WellSpring Pharmaceutical Corporation
Klinge Pharma
Caleb Pharmaceuticals
Perrigo Company
Baxter International

In Chapter 4 and Chapter 14.2, on the basis of types, the Motion Sickness Treatment market from 2018 to 2029 is primarily split into:

Anticholinergic
Antihistamines
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Motion Sickness Treatment market from 2018 to 2029 covers:

Hospitals
Clinics
Pharmacy
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)